Global Mycoplasma Testing Market 2023-2027

Description

List of Tables

The mycoplasma testing market is forecasted to grow by USD 645.51 mn during 2022-2027, accelerating at a CAGR of 12.25% during the forecast period. The report on the mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing focus on R and D of biopharmaceuticals, growing geriatric population, and rise in adoption of real-time mycoplasma testing.

Technavio's mycoplasma testing market is segmented as below:

By End-user

Pharmaceutical and biotechnology comp.
Cell banks
Academic research institutes
CROs
Others

By Product

Consumables
Systems

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising strategic alliances by vendors as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, the rising prevalence of mycoplasma pneumonia and concerns associated with pneumonia mortality and increasing initiatives for rapid diagnostics of infectious diseases will lead to sizable demand in the market.

The report on the mycoplasma testing market covers the following areas:

Mycoplasma testing market sizing
Mycoplasma testing market forecast
Mycoplasma testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mycoplasma testing market vendors that include Agilent Technologies Inc., ATCC, Akron Biotechnology LLC, Becton Dickinson and Co., Bio Techne Corp., Bionique Testing Laboratories Inc., Charles River Laboratories International Inc., DiaSorin SpA, Dilarus GmbH, F. Hoffmann La Roche Ltd., GeneCopoeia Inc., InvivoGen Corp., Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., PromoCell GmbH, Sartorius AG, ScienCell Research Laboratories Inc., SGS SA, and Thermo Fisher Scientific Inc.. Also, the mycoplasma testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43492

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global mycoplasma testing market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global mycoplasma testing market 2017 - 2021 ($ million)
4.2 End-user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
6.4 Cell banks - Market size and forecast 2022-2027
Exhibit 38: Chart on Cell banks - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Cell banks - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Cell banks - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Cell banks - Year-over-year growth 2022-2027 (%)
6.5 Academic research institutes - Market size and forecast 2022-2027
Exhibit 42: Chart on Academic research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Academic research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Academic research institutes - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Academic research institutes - Year-over-year growth 2022-2027 (%)
6.6 CROs - Market size and forecast 2022-2027
Exhibit 46: Chart on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on CROs - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on CROs - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by End-user
Exhibit 54: Market opportunity by End-user ($ million)
Exhibit 55: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 56: Chart on Product - Market share 2022-2027 (%)
Exhibit 57: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 58: Chart on Comparison by Product
Exhibit 59: Data Table on Comparison by Product
7.3 Consumables - Market size and forecast 2022-2027
Exhibit 60: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Consumables - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
7.4 Systems - Market size and forecast 2022-2027
Exhibit 64: Chart on Systems - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Systems - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Systems - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Systems - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 68: Market opportunity by Product ($ million)
Exhibit 69: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Agilent Technologies Inc.
Exhibit 119: Agilent Technologies Inc. - Overview
Exhibit 120: Agilent Technologies Inc. - Business segments
Exhibit 121: Agilent Technologies Inc. - Key offerings
Exhibit 122: Agilent Technologies Inc. - Segment focus
12.4 ATCC
Exhibit 123: ATCC - Overview
Exhibit 124: ATCC - Product / Service
Exhibit 125: ATCC - Key offerings
12.5 Akron Biotechnology LLC
Exhibit 126: Akron Biotechnology LLC - Overview
Exhibit 127: Akron Biotechnology LLC - Product / Service
Exhibit 128: Akron Biotechnology LLC - Key offerings
12.6 Becton Dickinson and Co.
Exhibit 129: Becton Dickinson and Co. - Overview
Exhibit 130: Becton Dickinson and Co. - Business segments
Exhibit 131: Becton Dickinson and Co. - Key news
Exhibit 132: Becton Dickinson and Co. - Key offerings
Exhibit 133: Becton Dickinson and Co. - Segment focus
12.7 Bio Techne Corp.
Exhibit 134: Bio Techne Corp. - Overview
Exhibit 135: Bio Techne Corp. - Business segments
Exhibit 136: Bio Techne Corp. - Key news
Exhibit 137: Bio Techne Corp. - Key offerings
Exhibit 138: Bio Techne Corp. - Segment focus
12.8 Bionique Testing Laboratories Inc.
Exhibit 139: Bionique Testing Laboratories Inc. - Overview
Exhibit 140: Bionique Testing Laboratories Inc. - Product / Service
Exhibit 141: Bionique Testing Laboratories Inc. - Key offerings
12.9 Charles River Laboratories International Inc.
Exhibit 142: Charles River Laboratories International Inc. - Overview
Exhibit 143: Charles River Laboratories International Inc. - Business segments
Exhibit 144: Charles River Laboratories International Inc. - Key news
Exhibit 145: Charles River Laboratories International Inc. - Key offerings
Exhibit 146: Charles River Laboratories International Inc. - Segment focus
12.10 F. Hoffmann La Roche Ltd.
Exhibit 147: F. Hoffmann La Roche Ltd. - Overview
Exhibit 148: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 149: F. Hoffmann La Roche Ltd. - Key news
Exhibit 150: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 151: F. Hoffmann La Roche Ltd. - Segment focus
12.11 GeneCopoeia Inc.
Exhibit 152: GeneCopoeia Inc. - Overview
Exhibit 153: GeneCopoeia Inc. - Product / Service
Exhibit 154: GeneCopoeia Inc. - Key offerings
12.12 InvivoGen Corp.
Exhibit 155: InvivoGen Corp. - Overview
Exhibit 156: InvivoGen Corp. - Product / Service
Exhibit 157: InvivoGen Corp. - Key offerings
12.13 Lonza Group Ltd.
Exhibit 158: Lonza Group Ltd. - Overview
Exhibit 159: Lonza Group Ltd. - Business segments
Exhibit 160: Lonza Group Ltd. - Key news
Exhibit 161: Lonza Group Ltd. - Key offerings
Exhibit 162: Lonza Group Ltd. - Segment focus
12.14 Merck KGaA
Exhibit 163: Merck KGaA - Overview
Exhibit 164: Merck KGaA - Business segments
Exhibit 165: Merck KGaA - Key news
Exhibit 166: Merck KGaA - Key offerings
Exhibit 167: Merck KGaA - Segment focus
12.15 Norgen Biotek Corp.
Exhibit 168: Norgen Biotek Corp. - Overview
Exhibit 169: Norgen Biotek Corp. - Product / Service
Exhibit 170: Norgen Biotek Corp. - Key offerings
12.16 Sartorius AG
Exhibit 171: Sartorius AG - Overview
Exhibit 172: Sartorius AG - Business segments
Exhibit 173: Sartorius AG - Key news
Exhibit 174: Sartorius AG - Key offerings
Exhibit 175: Sartorius AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 176: Thermo Fisher Scientific Inc. - Overview
Exhibit 177: Thermo Fisher Scientific Inc. - Business segments
Exhibit 178: Thermo Fisher Scientific Inc. - Key news
Exhibit 179: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 180: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 181: Inclusions checklist
Exhibit 182: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 183: Currency conversion rates for US$
13.4 Research methodology
Exhibit 184: Research methodology
Exhibit 185: Validation techniques employed for market sizing
Exhibit 186: Information sources
13.5 List of abbreviations
Exhibit 187: List of abbreviations